Rights and permissions
About this article
Cite this article
The glycopeptide antibacterial everninomycin [ziracin] shows `excellent' in vivo activity. Inpharma Wkly. 1236, 9 (2000). https://doi.org/10.2165/00128413-200012360-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012360-00019